Status:
COMPLETED
REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.
Lead Sponsor:
AstraZeneca
Conditions:
Treatment of Acute Coronary Syndrome (ACS).
Eligibility:
All Genders
18-130 years
Brief Summary
REWINDER is a multinational, multicentre, non-interventional, retrospective study of patients treated with an oral antiplatelet (ticagrelor, prasugrel or clopidogrel) while in hospital after an acute ...
Detailed Description
Treatment of acute coronary syndrome (ACS) with oral antiplatelets (OAPs) is recommended for up to 12 months unless discontinuation is clinically indicated. Early discontinuation could result in an in...
Eligibility Criteria
Inclusion
- The patient population that will be observed in the NIS must fulfil all of the following criteria:
- Female or male aged ≥18 years
- A patient information letter has been sent by the Investigator to the patient
- Patient discharged alive from this hospital to home following ACS (diagnosed with STEMI, NSTEMI or UA)
- ACS is either UA or myocardial infarction of Type 1 (spontaneous myocardial infarction related to ischemia due to a primary coronary event such as plaque erosion and/or rupture, fissuring, or dissection)
- ACS after 1st July 2012 and before 1st June 2013
- Patient on ticagrelor, prasugrel or clopidogrel treatment at discharge following an ACS
Exclusion
- Patients will not be eligible to participate if any of the following exclusion criteria are present:
- Patient who participated in any interventional clinical study during the observation period.
- Patient with ACS precipitated by or as complication of surgery, trauma, gastrointestinal bleeding or after Percutaneous Coronary Intervention (PCI)
- Patient with ACS occurring during a stay in the hospital
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT02190123
Start Date
September 1 2014
End Date
January 1 2015
Last Update
January 8 2016
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aalst, Belgium
2
Research Site
Baudour, Belgium
3
Research Site
Bonheiden, Belgium
4
Research Site
Brasschaat, Belgium